Log in to save to my catalogue

Low Risk of Treatment Failure after Substitution of Nevirapine for Protease Inhibitors among Human I...

Low Risk of Treatment Failure after Substitution of Nevirapine for Protease Inhibitors among Human I...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_18332615

Low Risk of Treatment Failure after Substitution of Nevirapine for Protease Inhibitors among Human Immunodeficiency Virus-Infected Patients with Virus Suppression

About this item

Full title

Low Risk of Treatment Failure after Substitution of Nevirapine for Protease Inhibitors among Human Immunodeficiency Virus-Infected Patients with Virus Suppression

Publisher

Chicago, IL: The University of Chicago Press

Journal title

The Journal of infectious diseases, 2002-05, Vol.185 (9), p.1261-1268

Language

English

Formats

Publication information

Publisher

Chicago, IL: The University of Chicago Press

More information

Scope and Contents

Contents

There is little information about the risk of treatment failure after a switch from human immunodeficiency virus (HIV) protease inhibitors (PIs) to nevirapine (Nvp) for patients with successful virus suppression. This study compared the 1-year risk of treatment failure for patients switching from a first PI-containing antiretroviral regimen to Nvp...

Alternative Titles

Full title

Low Risk of Treatment Failure after Substitution of Nevirapine for Protease Inhibitors among Human Immunodeficiency Virus-Infected Patients with Virus Suppression

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_18332615

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_18332615

Other Identifiers

ISSN

0022-1899

E-ISSN

1537-6613

DOI

10.1086/340131

How to access this item